1-6 of 6
Keith B. Glaser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML

Jianbiao Zhou, Chonglei Bi, Jasinghe V. Janakakumara, Shaw-Cheng Liu, Wee-Joo Chng, Kian-Ghee Tay, Lai-Fong Poon, Zhigang Xie, Senthilnathan Palaniyandi, Hanry Yu, Keith B. Glaser, Daniel H. Albert, Steven K. Davidsen, Chien-Shing Chen
Journal: Blood
Blood (2009) 113 (17): 4052–4062.
https://doi.org/10.1182/blood-2008-05-156422
Published: 2009
Includes: Supplemental data
Journal Articles

Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis and Inhibition of Proliferation of Ba/F3 FLT-3 ITD Mutant Cells.

Jenny E. Hernandez, BS, Junling Li, Ru-Qi Wei, Paul Tapang, Steven K. Davidsen, PhD, Daniel H. Albert, PhD, Patrick A. Marcotte, PhD, Keith B. Glaser, PhD, Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D. PhD.
Journal: Blood
Blood (2007) 110 (11): 1589.
https://doi.org/10.1182/blood.V110.11.1589.1589
Published: 2007
Journal Articles

Overactivation of STAT Pathways and Overexpression of Survivin Confer Resistance to FLT3 Inhibitors and Could Be Therapeutic Targets in AML.

Jianbiao Zhou, MD, MSc, Chonglei Bi, B.S., Lai Fong Poon, B.S., Viraj J. Janakakumara, B.S., Jiaying Khng, Hanry Yu, Ph.D., Keith B. Glaser, Ph.D., Daniel H. Albert, Ph.D., Davidsen K. Davidsen, Ph.D., Chien-Shing Chen, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2367.
https://doi.org/10.1182/blood.V110.11.2367.2367
Published: 2007
Journal Articles

Targeting FLT3 Phosphorylation and Signaling in Acute Myeloid Leukemia.

Alan K. Ikeda, MD, Dejah Judelson, Junling Li, Ru Qi Wei, Paul Tapang, Steven K. Davidsen, Ph.D., Dan H. Albert, Ph.D., Keith B. Glaser, Ph.D., Cecilia Fu, M.D., Kathleen M. Sakamoto, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 912.
https://doi.org/10.1182/blood.V110.11.912.912
Published: 2007
Journal Articles

ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia

Deepa B. Shankar, Junling Li, Paul Tapang, J. Owen McCall, Lori J. Pease, Yujia Dai, Ru-Qi Wei, Daniel H. Albert, Jennifer J. Bouska, Donald J. Osterling, Jun Guo, Patrick A. Marcotte, Eric F. Johnson, Niru Soni, Kresna Hartandi, Michael R. Michaelides, Steven K. Davidsen, Saul J. Priceman, Jenny C. Chang, Katrin Rhodes, Neil Shah, Theodore B. Moore, Kathleen M. Sakamoto, Keith B. Glaser
Journal: Blood
Blood (2007) 109 (8): 3400–3408.
https://doi.org/10.1182/blood-2006-06-029579
Published: 2007
Includes: Supplemental data
Journal Articles

The Multi-Targeted Receptor Tyrosine Kinase Inhibitor, ABT-869, Induces Apoptosis of AML Cells Both In Vitro and In Vivo.

Deepa B. Shankar, PhD, Jenny C. Chang, Bertrand Parcells, Salemiz Sandoval, Junling Li, Ru-Qi Wei, Paul Tapang, Steven K. Davidsen, PhD, Dan H. Albert, PhD, Keith B. Glaser, PhD, Theodore B. Moore, MD, Kathleen M. Sakamoto, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 616.
https://doi.org/10.1182/blood.V106.11.616.616
Published: 2005